Mechanism of Action of Blenrep
Introduction Blenrep is the brand name of belantamab mafodotin-blmf, an anticancer biologic used in relapsed or refractory multiple myeloma. Pharmacologically, Blenrep is a B-cell maturation antigen-directed antibody-drug conjugate, commonly called a BCMA-directed ADC. Multiple myeloma is a plasma-cell malignancy in which abnormal plasma cells multiply in the bone marrow and produce monoclonal immunoglobulin or light … Read more